Meditab Specialities Limited

Meditab Specialities Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U23240MH1996PLC104442 Incorporated 11 December 1996 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹40.03 Cr
▼ 90.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹80.86 Lakh
Issued & subscribed
Open charges
None
Secured borrowings
Company age
30 yrs
Est. 1996
Employees · EPFO
126
Latest available

About Meditab Specialities Limited

Data last updated: 06 January 2026

Meditab Specialities Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Cipla Limited. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 11 December 1996, the company has been in operation for over 30 years.

Registered with ROC Mumbai under CIN U23240MH1996PLC104442.

Capital: an authorised share capital of ₹1 Cr and a paid-up capital of ₹80.86 Lakh. Formerly known as Meditab Specialities Private Limited. It is led by directors including Dinesh Ramniranjan Jain and Anisha Naresh Udeshi.

Last AGM: 18 September 2025. Financial statements filed for year ended 31 March 2025. Office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013.

As per the financials filed for FY 2025, the company reported a revenue of ₹40.03 Cr, a decline of 90% compared to the previous year.

The company has a workforce of approximately 126 employees as per the latest available data. It operates as a subsidiary of Cipla Limited. Its group structure includes 2 subsidiaries.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cipla.com.

Company Details of Meditab Specialities Limited
CIN U23240MH1996PLC104442
Registration Number 104442
Incorporation Date 11 December 1996
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 18 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Cipla Limited
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013
  • Industry
    Pharma, Drug Formulation & Development
Company report
Meditab Specialities Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Meditab Specialities Limited report

Financials, compliance, directors, charges, ownership and filings for Meditab Specialities Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Meditab Specialities Limited

Meditab Specialities Limited has one previous CIN (Corporate Identification Number): U23240MH1996PTC104442. The current CIN is U23240MH1996PLC104442, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U23240MH1996PLC104442 Current
U23240MH1996PTC104442 Previous

Business Activity of Meditab Specialities Limited

Meditab Specialities Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Meditab Specialities Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Meditab Specialities Limited

Meditab Specialities Limited is audited by Walker Chandiok & Co LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Walker Chandiok & Co LLP Locked Locked Locked
Premium access

Complete auditor history for Meditab Specialities Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Meditab Specialities Limited

Meditab Specialities Limited currently reports 4 directors and 1 key managerial person. 16 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Dinesh Ramniranjan Jain Director 03 Jan 2019 7 Years 6 Months Current
Anisha Naresh Udeshi Director 23 Aug 2021 4 Years 10 Months Current
Sanjay Kumar Mishra Managing Director 21 Oct 2022 3 Years 8 Months Current
Girish Zamwar Cfo 05 Mar 2020 6 Years 4 Months Current
Rajendra Kumar Chopra Director 11 Nov 2024 1 Years 8 Months Current

Financials of Meditab Specialities Limited FY 2025 filings available

Meditab Specialities Limited reported revenue of ₹40.03 Cr (down 90.00% YoY) for FY 2025.

Revenue · FY 2025
₹40.03 Cr ▼ 90.00%
Premium access

Ten-year financial statements for Meditab Specialities Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Meditab Specialities Limited

Premium access

Shareholding and ownership data for Meditab Specialities Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Meditab Specialities Limited

Meditab Specialities Limited has 2 subsidiary companies and 1 associated company. This group structure data is as of FY 2023. The corporate group structure reflects Meditab Specialities Limited's business expansion strategy and organizational complexity.

2
Subsidiary companies
1
Associated companies
Key Subsidiaries
Company Name CIN Shares Held
Medispray Laboratories Private Limited U52311GA1992PTC002801 Locked
Sitec Labs Limited U74999MH2000PLC129210 Locked

Showing major subsidiaries. Total: 2.

Charges & Borrowings Meditab Specialities Limited

Meditab Specialities Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Meditab Specialities Limited

Meditab Specialities Limited has a workforce of 126 employees as of Apr 02, 2024.

Employee count
126
Active EPFO establishments
2
Employee growth
17.76%
Premium access

Employee and EPFO history for Meditab Specialities Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Meditab Specialities Limited

Premium access

GST registrations and filing compliance for Meditab Specialities Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Meditab Specialities Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Meditab Specialities Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Meditab Specialities Limited

Premium access

MSME payment history for Meditab Specialities Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Meditab Specialities Limited

Premium access

Corporate group structure for Meditab Specialities Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Meditab Specialities Limited

Premium access

MCA filings and documents for Meditab Specialities Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Meditab Specialities Limited

Activity
18 Sep 2025
Meditab Specialities Limited last Annual general meeting of members was held on 18 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Meditab Specialities Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
11 Nov 2024
Rajendra Kumar Chopra was appointed as a Director on 11 Nov 2024 & has been associated with this company since 1 year 8 months.
Directors
26 Sep 2023
Pavan Kumar Kadedin Yadav was appointed as a Company Secretary on 26 Sep 2023 & has been associated with this company since 2 years 9 months.
Directors
21 Oct 2022
Sanjay Kumar Mishra was appointed as a Managing Director on 21 Oct 2022 & has been associated with this company since 3 years 8 months.
Directors
23 Aug 2021
Anisha Naresh Udeshi was appointed as a Director on 23 Aug 2021 & has been associated with this company since 4 years 10 months.

Frequently Asked Questions about Meditab Specialities Limited

Meditab Specialities Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 11 December 1996 (30+ years old) and is registered under CIN U23240MH1996PLC104442. The company has 126 employees.

Meditab Specialities Limited reported revenue of ₹40.03 Cr for FY 2025 (down 90.00% YoY).

The current directors and KMP of Meditab Specialities Limited are:

The primary industry of Meditab Specialities Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Meditab Specialities Limited can be reached at the registered office: Tower A 1St Floor Peninsula Business Park Ganpatrao Kadam Marg Lower Parel, Mumbai, Maharashtra, India – 400013, or through the website cipla.com.

The authorised capital is ₹1 Cr, and the paid-up capital is ₹80.86 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available